Contact
Competence
Services
Home

Axel Obermeier Life Science Consulting  - AOLSC -

Collaboration

1. Project Evaluation (eNPV) and Licensing Support

a) Scientific/Technical Analysis and Financial Valuation of R&D Projects

Method:

Risk-adjusted and option-augmented determination of the expected net

present value (eNVP), based on the discounted cash flow method

Modules:

    ·         Product target profile

    ·         Decision tree (reflecting development risks, strategies, timelines and milestones)

    ·         Market model

- Epidemology (populations, incidence/prevalence, future extrapolations)

- Market segmentations and patient share (considering age, gender,

       race, state of health, comorbidities, co-medication, 1st/2nd line therapy,

     pre-treatments, ...)

 - Treatment modalities and strategies

 - Detailed competitor and R&D pipeline analysis (and impact on

      market share)

 - Market penetration and product lifecycle curve

 - Product pricing, price trends and distribution costs

 --> Regional and worldwide sales forecasts

   ·         Intellectual property incl. freedom-to-operate (FTO) analysis

   ·         Costs and financial figures

-  Development costs
-  Cost of goods
-
a
 Promotional costs (marketing, sales force, DTC) and marketing  strategies; G&A
-  Discount rate, taxes, inflation rates and other financial figures 

               ·         Financial model

                     - Discounted cash flows (DCF)

-->
a
Scenario NPVs, regional and overall eNVP (risk adjusted, option augmented)

            ·         eNVP projections (future increase of eNPV upon successful completion

                  of milestones)

                   ·         Monte Carlo simulation (statistical parameters reflecting uncertainties

                  of assumptions)

               ·         Sensitivity analysis (variation of input variables to test their impact on

                    key results; alternative scenario modeling)

    b) Drafting of Licensing Deal Terms

                        ·         Generation of a license calculator (modeling of alternative deal term scenarios)

                        ·         Interactive determination of optimal deal terms (upfront and milestone

                payments, royalties and other options)

                        ·         Determination of appropriate licensee/licensor value splits

              

   

    2. R&D Portfolio and Pipeline Analysis


    3. Optimization of Preclinical Research

 

    4R&D Benchmarking

 

    5. Multi-Stakeholder Projects

 

    6. Dedicated Investigations (Competition, Market Research)

 

    7. Generation of Documents and Brochures

 

    8. Part-Time Interims Management